Genetic context for the GLP-1 pathway The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
Safety of exenatide once weekly in patients with type 2 diabetes mellitus treated with a thiazolidinedione alone or in combination with metformin for 2 years
Answer: Retatrutide is an investigational once-weekly injectable peptide that activates three hormone receptor systems at once, GLP-1, GIP, and glucagon, to slow digestion, improve insulin response, and directly burn stored fat
Ask whether a medication is approved for your condition, what label-backed dose instructions apply, how side effects are monitored, and what follow-up is needed